59 related articles for article (PubMed ID: 32318326)
1. Knockdown of KIF15 suppresses proliferation of prostate cancer cells and induces apoptosis through PI3K/Akt signaling pathway.
Bi H; Hou X; Shen Q; Liu Z; Zhu X; Ma L; Lu J
Cell Death Discov; 2023 Sep; 9(1):326. PubMed ID: 37658042
[TBL] [Abstract][Full Text] [Related]
2. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
[TBL] [Abstract][Full Text] [Related]
3. Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.
Cai Y; Lai Q; Zhang X; Zhang Y; Zhang M; Gu S; Qin Y; Hou J; Zhao L
Korean J Physiol Pharmacol; 2023 Sep; 27(5):457-470. PubMed ID: 37641808
[TBL] [Abstract][Full Text] [Related]
4. Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
Qi ZY; Wang F; Yue YY; Guo XW; Guo RM; Li HL; Xu YY
J Ovarian Res; 2023 Aug; 16(1):174. PubMed ID: 37626400
[No Abstract] [Full Text] [Related]
5. Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma.
Mi J; Ma S; Chen W; Kang M; Xu M; Liu C; Li B; Wu F; Liu F; Zhang Y; Wang R; Jiang L
Front Oncol; 2022; 12():772816. PubMed ID: 35359374
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract][Full Text] [Related]
7. Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma.
Wang F; Breslin S J P; Qiu W
Liver Res; 2021 Dec; 5(4):195-203. PubMed ID: 34900376
[TBL] [Abstract][Full Text] [Related]
8. K-fiber bundles in the mitotic spindle are mechanically reinforced by Kif15.
Begley MA; Solon AL; Davis EM; Sherrill MG; Ohi R; Elting MW
Mol Biol Cell; 2021 Dec; 32(22):br11. PubMed ID: 34668719
[TBL] [Abstract][Full Text] [Related]
9. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
10. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
11. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
[TBL] [Abstract][Full Text] [Related]
12. KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma.
Sun YF; Wu HL; Shi RF; Chen L; Meng C
Anal Cell Pathol (Amst); 2020; 2020():6403012. PubMed ID: 32318326
[TBL] [Abstract][Full Text] [Related]
13. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma.
Li Q; Qiu J; Yang H; Sun G; Hu Y; Zhu D; Deng Z; Wang X; Tang J; Jiang R
Cancer Lett; 2020 Jul; 482():112-125. PubMed ID: 31733289
[TBL] [Abstract][Full Text] [Related]
14. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
[TBL] [Abstract][Full Text] [Related]
15. KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma.
Kitagawa A; Masuda T; Takahashi J; Tobo T; Noda M; Kuroda Y; Hu Q; Kouyama Y; Kobayashi Y; Kuramitsu S; Sato K; Fujii A; Yoshikawa Y; Wakiyama H; Shimizu D; Tsuruda Y; Eguchi H; Doki Y; Mori M; Mimori K
Cancer Genomics Proteomics; 2020; 17(2):141-149. PubMed ID: 32108036
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
